Hana Pharm Co., Ltd. (293480.KS)
KRW 10850.0
(-0.73%)
KRW 10850.0
(-0.73%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1291.00 KRW | -8.12% |
| 2022 | 1405.08 KRW | -16.32% |
| 2021 | 1679.05 KRW | 95.07% |
| 2020 | 860.74 KRW | -46.76% |
| 2019 | 1616.79 KRW | -9.93% |
| 2018 | 1794.94 KRW | -11.97% |
| 2017 | 2039.09 KRW | -0.22% |
| 2016 | 2043.64 KRW | 641.5% |
| 2015 | 275.61 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 351.17 KRW | 10.75% |
| 2024 Q2 | 290.84 KRW | -17.18% |
| 2023 Q3 | 221.12 KRW | -50.39% |
| 2023 Q4 | 317.09 KRW | 43.4% |
| 2023 Q1 | 307.01 KRW | -22.79% |
| 2023 Q2 | 445.73 KRW | 45.18% |
| 2023 FY | - KRW | -8.12% |
| 2022 FY | - KRW | -16.32% |
| 2022 Q4 | 397.63 KRW | 25.8% |
| 2022 Q3 | 316.08 KRW | -6.76% |
| 2022 Q2 | 339.00 KRW | -3.81% |
| 2022 Q1 | 352.41 KRW | -17.15% |
| 2021 FY | - KRW | 95.07% |
| 2021 Q2 | 532.00 KRW | 106.06% |
| 2021 Q1 | 258.18 KRW | 206.88% |
| 2021 Q4 | 425.37 KRW | -5.05% |
| 2021 Q3 | 448.00 KRW | -15.79% |
| 2020 Q3 | 480.00 KRW | 60.0% |
| 2020 Q2 | 300.00 KRW | -6.78% |
| 2020 FY | - KRW | -46.76% |
| 2020 Q1 | 321.82 KRW | -18.46% |
| 2020 Q4 | -241.56 KRW | -150.33% |
| 2019 Q1 | 381.82 KRW | -33.37% |
| 2019 FY | - KRW | -9.93% |
| 2019 Q4 | 394.66 KRW | -9.37% |
| 2019 Q3 | 435.45 KRW | 8.12% |
| 2019 Q2 | 402.73 KRW | 5.48% |
| 2018 Q3 | 492.73 KRW | 11.52% |
| 2018 Q1 | 416.36 KRW | 0.0% |
| 2018 FY | - KRW | -11.97% |
| 2018 Q4 | 573.01 KRW | 16.29% |
| 2018 Q2 | 441.82 KRW | 6.11% |
| 2017 FY | - KRW | -0.22% |
| 2017 Q3 | 565.45 KRW | 0.0% |
| 2016 FY | - KRW | 641.5% |
| 2015 FY | - KRW | 0.0% |